A prognostic model for breast cancer survival based on PCD and m6A gene interactions
This study constructed a risk model based on seven prognostic genes, offering new potential strategies for breast cancer therapy.
Authors
- Zhan Meng (ORCID: https://orcid.org/0000-0002-4118-557X)
- Guoxu Zheng (ORCID: https://orcid.org/0000-0002-7548-5028)
- Weimiao Li (ORCID: https://orcid.org/0000-0002-8116-3068)
- Haocheng Bai
- Shuqun Zhang (ORCID: https://orcid.org/0000-0003-2959-6461)
- Jiajing Yang
Institutions
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-11-20
- DOI
- https://doi.org/10.3389/fimmu.2025.1711910
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China